2023-11-02 08:37:27 ET
- Losers: Confluent CFLT -34% after Q3 earning release .
- Remitly Global RELY -23% after Q3 earning release .
- Acurx Pharmaceuticals ( ACXP ) -18% announces positive top-line Ibezapolstat phase 2 efficacy results with 96% clinical cure rate in patients with C. difficile infection.
- Procore Technologies PCOR -18% after Q3 earning release .
- Envista Holdings Corp NVST -17% after Q3 earning release .
- Tandem Diabetes Care TNDM -16% after Q3 earning release .
- Solaredge Technologies SEDG -14% after Q3 earning release .
- Crocs CROX -13% after Q3 earning release .
- Moderna MRNA -11% after Q3 earning release .
- QuinStreet QNST -11% after Q1 earning release .
- Peloton Interactive PTON -7% after Q1 earning release .
- Tempur Sealy International TPX -7% after Q3 earning release .
- Werewolf Therapeutics ( HOWL ) -7% .
- Troika Media Group ( TRKA ) -6% .
- Sunrun RUN -6% after Q3 earning release .
For further details see:
QNST, HOWL and TRKA among pre-market losers